Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00875836 · ClinicalTrials.gov registry record · Phase 4

Buspirone Treatment for Marijuana Dependence

A Phase 4 study of Marijuana Dependence, sponsored by Medical University of South Carolina.

Completed
Registry status
Phase 4
Development phase
175
Enrollment target
1
Study location

NCT00875836 is a Phase 4 study of Marijuana Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 175 participants, above the 63-participant average among 6 other Marijuana Dependence trials with a reported enrollment target (178% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00875836, a Phase 4 study of Marijuana Dependence, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
Phase 4
Development phase
175 participants
Enrollment target
1
Study location

Study Summary

Marijuana is the most commonly used illicit drug, yet few clinical trials have evaluated pharmacotherapy treatments for marijuana dependence. This study will evaluate the efficacy of buspirone for reducing marijuana use in marijuana-dependent adults. A contingency management (CM) intervention and motivational enhancement therapy (MET) will be incorporated to encourage study engagement and retention. It is hypothesized that buspirone combined with MET and CM will reduce the percent of marijuana-positive urine drug screen results in marijuana-dependent individuals as compared to a placebo treatment combined with MET and CM.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Buspirone

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2009-09
Est. Completion 2016-03
Phase Phase 4

What the Registry Record Tells You About NCT00875836

The ClinicalTrials.gov registry entry for NCT00875836 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 63-participant average among 6 other Marijuana Dependence trials with a reported enrollment target (178% higher). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Marijuana Dependence appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00875836 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT00875836 about?

NCT00875836 is a clinical study titled "Buspirone Treatment for Marijuana Dependence". Marijuana is the most commonly used illicit drug, yet few clinical trials have evaluated pharmacotherapy treatments for marijuana dependence. This study will evaluate the efficacy of buspirone for reducing marijuana use in marijuana-dependent adults. A contingency management (CM) intervention and mo...

What is the current status of trial NCT00875836?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 175 participants. The study started on 2009-09. Estimated completion is 2016-03.

What conditions does trial NCT00875836 study?

This clinical trial studies the following conditions: Marijuana Dependence.

What interventions are being tested in trial NCT00875836?

The interventions under investigation include: Placebo (DRUG), Buspirone (DRUG).

Who is sponsoring clinical trial NCT00875836?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00875836 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Marijuana Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.